about
Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients.Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.Potassium-binding resins: Associations with serum chemistries and interdialytic weight gain in hemodialysis patients.Buttonhole Cannulation Is Not Associated with More AVF Infections in a Low-Care Satellite Dialysis Unit: A Long-Term Longitudinal Study.Cutaneous Mycobacterium chelonae infection distal to the arteriovenous fistula.A Swelling in the Mouth in a Chronic Hemodialysis Patient.Infectious complications following conversion to buttonhole cannulation of native arteriovenous fistulas: a quality improvement report.What are the causes of the ill effects of chronic hemodialysis? Toward a reduction in the risk of electrolyte-related sudden death.Sailing between Scylla and Charybdis: the high serum K-low dialysate K quandary.Con: Frequent haemodialysis for all chronic haemodialysis patients.Any use for alternative lock solutions in the prevention of catheter-related blood stream infections?Unusual skin lesions in a haemodialyzed patient.Moderator's View: Buttonhole cannulation of arteriovenous fistulae: great caution is warranted.Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative EndocarditisBarriers to adopting a fistula-first policy in Europe: an international survey among national experts.Acute heart failure after thrombotic thrombocytopenic purpura successfully treated by ECLS.Arteriovenous fistula infection as a cause of vascular access hemorrhage.The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations.Vancomycin catheter lock as a cause of gross overestimation of vancomycin pre-dialysis trough levels.Opponent's comment.Atopobium rimae bacteremia complicated by an infection-related glomerulonephritis in a cardiac transplanted patient.Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP).Persistence of beta2-microglobulin amyloidosis 20 years after successful kidney transplantationOutcome of kidney transplantation in familial juvenile hyperuricaemic nephropathyNew recommendations in the treatment of Gram-positive bacteraemia in dialysis patientsClostridium perfringens hip arthritis in a haemodialysis patientCatheter-related blood stream infections (CRBSI): a European viewThe decades-long fight against HBV transmission to dialysis patients: slow but definite progressIntravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney diseaseHaemodialysis is a major risk factor for infective endocarditisDialysis-related Amyloidosis: Is It Gone or Should It Be?Sodium polystyrene sulfonate: still news after 60 years on the marketThe Case | Severe acute hypocalcemia in a patient on hemodialysis
P50
Q30399027-0873995E-2C89-4877-A7C4-DB32E2C51B0DQ33309156-FED815AE-85F1-4E39-9323-A46E996899E1Q33794591-5889E841-0537-48E7-9322-7E9BE32FCB95Q35843535-5C3C2600-B4AF-4810-9ED5-73854F2F3929Q37284123-DC751CCC-F42B-4A5F-86E3-B7D49DBA6814Q37359095-C9DECC0F-6CD9-45C3-9AA9-0CE5E286098DQ37826971-099172DE-5341-4AC2-B1F5-85F395966BD3Q38155910-F5AD21CB-09AB-46F8-84DD-EF530356236BQ38211496-CD47A43D-A8C9-4ACB-B4B7-C09AFCD78C7FQ38299704-785D3C28-7D95-4352-A80A-8D0B5782D198Q39180352-A442AE23-931D-46FF-8B24-A25C97F74015Q40337893-891496F0-E28C-41D7-9C64-7950C24FDAE4Q40749078-B252A209-C59E-44F7-A951-455EEC5DBAE5Q42227765-4DDFE483-34D4-4939-8026-D3EBD00311CDQ42691435-C635079E-AF94-47B9-9F2C-926E14A34535Q43453308-50CE0C93-1B49-40FA-90CE-96B4DAD106ECQ43798144-AE267890-36FA-44D0-A8E7-7A2A7013E1A2Q43869224-44FF4563-2195-4710-A14E-87FB179491F0Q45108435-036B6B45-BAB6-46B4-95BD-9F01433F410DQ45959134-D6ED48DB-0DB4-4CC6-BAC4-EA6F3E4B18BBQ54603445-CE703E75-1A65-4C5D-A952-40BD10AE1561Q64958368-261AD88D-D472-49A6-BE20-BEF2D946CAFAQ80526789-DA334860-1753-4FFC-A394-694C72E995C7Q80535371-3464086F-E13E-4284-8EA6-047AE46BF0A9Q81119006-ADEA380D-8A08-4247-BA7B-E121CA71E936Q83819358-7619FAB6-94E0-46AD-ADC0-7F69946199F2Q84217279-43667B62-D99C-4558-8FF6-BA9F2CB3D499Q84217353-D9642F3B-32CB-4479-ACB8-3F6F30D25D3DQ87407572-90828BD6-1C44-4B1F-A5A9-ED40A0776323Q88031732-24FF341C-1488-464F-9BE6-8464C0DC6B7BQ89420053-BF8AFC87-4FFB-4A5D-9A2F-B05917A646D2Q89627716-099D3686-AC4D-4C0E-8B27-D7D07DA4BFB6Q89843074-39944CE1-5A93-4B6D-85C7-3EDCEB8F6E78
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Labriola
@ast
Laura Labriola
@en
Laura Labriola
@es
Laura Labriola
@nl
Laura Labriola
@sl
type
label
Laura Labriola
@ast
Laura Labriola
@en
Laura Labriola
@es
Laura Labriola
@nl
Laura Labriola
@sl
prefLabel
Laura Labriola
@ast
Laura Labriola
@en
Laura Labriola
@es
Laura Labriola
@nl
Laura Labriola
@sl
P106
P1153
16643087400
P21
P31
P496
0000-0003-4133-881X